Global Sickle Cell Anemia Market Report By Treatment (Blood Transfusion, Pharmacotherapy And Bone Marrow Transplant) And By Regions - Industry Trends, Size, Share, Growth, Estimation And Forecast, 2018-2025
ID:VMR11210523
February 2019
Report Formats:

As per this study the Global Sickle Cell Anemia Market was valued USD XX.X MN (by revenue) in 2018 and is anticipated to reach USD XX.X MN by 2025 with a CAGR of X.X%.

Sickle cell anemia also is known as sickle cell disease is the type of blood disorder that affects red blood cells that leads to a reduction in their oxygen carrying capacity. Extreme tiredness or fatigueness, periodic episodes of pain, frequent infections, and vision problems are some of the common symptoms of sickle cell anemia. Some of the effective treatments to cure sickle cell anemia are stem cell transplant, pharmacology, and blood transfusion along with medication to prevent and minimize complications.
 
Market Dynamics
 
Increase in a count of the population suffering from blood-related disorders especially in underdeveloped nations is driving the demand for effective treatment. Growing awareness regarding the disease, favorable governmental initiatives and improvement in healthcare services is again boosting the market growth. Also, the rise in funding by the government towards genetic therapies to cure such diseases is further promoting the market growth. However, the high cost of treatment is likely to hinder the market growth.
 
This detailed market study is centered on the data obtained from multiple sources and is analyzed using numerous tools including porter’s five forces analysis, market attractiveness analysis and value chain analysis. These tools are employed to gain insights of the potential value of the market facilitating the business strategists with the latest growth opportunities. Additionally, these tools also provide a detailed analysis of each application/product segment in the global market of sickle cell anemia.
 
Market Segmentation
 
The broad sickle cell anemia market has been sub-grouped into treatment. The report studies these subsets with respect to the geographical segmentation. The strategists can gain a detailed insight and devise appropriate strategies to target specific market. This detail will lead to a focused approach leading to identification of better opportunities.
 
By Treatment

  • Blood Transfusion
  • Pharmacotherapy
  • Bone Marrow Transplant
 
Regional Analysis
 
Furthermore, the report comprises of the geographical segmentation which mainly focuses on current and forecast demand for sickle cell anemia in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The report further focuses on demand for individual application segments in all the regions.
 
Europe Sickle Cell Anemia Market By Revenue (USD MN)
 
Europe Sickle Cell Anemia Market By Revenue
 
The report also covers detailed competitive landscape including company profiles of key players operating in the global market. The key players in the sickle cell anemia market include Bluebird Bio, Emmaus Life Sciences, Global Blood Therapeutics, Novartis and Pfizer among others. An in-depth view of the competitive outlook includes future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other developments with information in terms of H.Q.
 
 
METHODOLOGY:
 
A combination of primary and secondary research has been used to determine the market estimates and forecasts. Sources used for secondary research include (but not limited to) Paid Data Sources, Company Websites, Technical Journals, Annual Reports, SEC Filings and various other industry publications. Specific details on methodology used for this report can be provided on demand.

1. INTRODUCTION

  • Introduction To Sickle Cell Anemia
  • Report Description
    • Objectives Of The Study
    • Assumptions
  • Research Scope
  • Research Methodology
    • Data Source
 
2. EXECUTIVE SUMMARY
  • Market Highlight
  • Global Sickle Cell Anemia Market: Snapshot
 
3. MARKET ANALYSIS
  • Drivers
  • Restraints
  • Opportunities
  • Porter’s Five Forces Analysis
  • Value Chain Analysis
 
4. SICKLE CELL ANEMIA MARKET ANALYSIS BY TREATMENT
  • Market In Blood Transfusion
  • Pharmacotherapy
  • Bone Marrow Transplant
 
5. SICKLE CELL ANEMIA MARKET ANALYSIS BY GEOGRAPHY
  • North America (NA)
    • North America Market Estimates
    • North America Market Estimates By Country
    • United States (U.S.) Market Estimates By Segments
    • Rest Of North America Market Estimates By Segments
  • Europe (EU)
    • Europe Market Estimates
    • Europe Market Estimates By Country
    • United Kingdom (UK) Market Estimates By Segments
    • Germany Market Estimates By Segments
    • France Market Estimates By Segments
    • Rest Of Europe Market Estimates By Segments
  • Asia Pacific (APAC)
    • Asia Pacific Market Estimates
    • Asia Pacific Market Estimates By Country  
    • China Market Estimates By Segments
    • Japan Market Estimates By Segments
    • India Market Estimates By Segments
    • Rest Of Asia Pacific Market Estimates By Segments  
  • Latin America (LA)   
    • Latin America Market Estimates
    • Latin America Market Estimates By Country
    • Brazil Market Estimates By Segments
    • Rest Of Latin America Market Estimates By Segments
  • Middle East And Africa (MEA)   
    • Middle East And Africa Market Estimates
    • Middle East And Africa Market Estimates By Country
    • Middle East Market Estimates By Segments
    • Africa Market Estimates By Segments
 
6. COMPETITIVE LANDSCAPE OF THE SICKLE CELL ANEMIA COMPANIES
  • Market Competition
  • Partnerships/Collaborations/Agreements
  • Mergers And Acquisitions
  • New Product Launches
  • Other Developments
 
7. COMPANY PROFILES OF THE SICKLE CELL ANEMIA INDUSTRY (Company Overview, Financial, Major Products & Recent Development)
  • Bluebird Bio
  • Emmaus Life Sciences
  • Global Blood Therapeutics
  • Novartis
  • Pfizer
 
* Tentative TOC
 
LIST OF TABLES
 
Table 1.  Market Highlights Of Sickle Cell Anemia
Table 2.  Global Sickle Cell Anemia Market By Treatment
Table 3.  Global Sickle Cell Anemia Market By Geography
Table 4.  North America Sickle Cell Anemia Market
Table 5.  Europe Sickle Cell Anemia Market
Table 6.  Asia Pacific Sickle Cell Anemia Market
Table 7.  Latin America Sickle Cell Anemia Market
Table 8.  Middle East And Africa Sickle Cell Anemia Market 
Table 9.  Partnership/Collaboration/Agreements
Table 10. Mergers And Acquisitions
Table 11. New Product Development
Table 12. Other Developments
  
LIST OF FIGURES
 
Fig. 1.     Market Segmentation Of Sickle Cell Anemia Market 
Fig. 2.     Top-Down Approach   
Fig. 3.     Bottom-Up Approach   
Fig. 4.     Market Highlights Of Sickle Cell Anemia
Fig. 5.     Porter’s Five Forces Analysis
Fig. 6.     Value Chain Analysis
Fig. 7.     Global Sickle Cell Anemia Market By Treatment
Fig. 8.     Global Sickle Cell Anemia Market By Geography
Fig. 9.     North America Sickle Cell Anemia Market
Fig. 10.   Europe Sickle Cell Anemia Market
Fig. 11.   Asia Pacific Sickle Cell Anemia Market
Fig. 12.   Latin America Sickle Cell Anemia Market
Fig. 13.   Middle East And Africa Sickle Cell Anemia Market
Fig. 14.   Market Share Of Sickle Cell Anemia Companies
Fig. 15.   Recent Developments In Sickle Cell Anemia Industry
 
 
* Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

Objectives of Study

  • Define and measure the global market
  • Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
  • Analyze and identify major market trends along with the factors driving or inhibiting the market growth
  • Study the company profiles of the major market players with their market share
  • Analyze competitive developments

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Why Choose Us

Client First Policy
Excellent Quality
Robust After Sales Support
24/7 Email Support

Clients

Testimonials